Treace Medical Concepts, Inc.
TMCI
$6.74
-$0.255-3.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.89% | 16.14% | 18.90% | 26.48% | 31.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.89% | 16.14% | 18.90% | 26.48% | 31.92% |
| Cost of Revenue | 16.80% | 20.16% | 24.49% | 31.04% | 37.79% |
| Gross Profit | 10.75% | 15.21% | 17.64% | 25.46% | 30.64% |
| SG&A Expenses | 8.21% | 17.83% | 26.26% | 29.37% | 36.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.06% | 18.96% | 26.28% | 29.20% | 35.01% |
| Operating Income | -8.08% | -29.23% | -55.84% | -39.59% | -47.59% |
| Income Before Tax | -12.55% | -29.09% | -50.66% | -15.91% | -15.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.55% | -29.09% | -50.66% | -15.91% | -15.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.55% | -29.09% | -50.66% | -15.91% | -15.68% |
| EBIT | -8.08% | -29.23% | -55.84% | -39.59% | -47.59% |
| EBITDA | -3.41% | -25.48% | -51.74% | -34.20% | -42.39% |
| EPS Basic | -10.20% | -25.15% | -41.65% | -5.90% | -5.25% |
| Normalized Basic EPS | -10.03% | -26.05% | -42.79% | -18.09% | -18.62% |
| EPS Diluted | -10.52% | -25.15% | -41.65% | -5.90% | -5.25% |
| Normalized Diluted EPS | -10.03% | -26.05% | -42.79% | -18.09% | -18.62% |
| Average Basic Shares Outstanding | 2.09% | 4.46% | 6.94% | 9.52% | 10.06% |
| Average Diluted Shares Outstanding | 2.09% | 4.46% | 6.94% | 9.52% | 10.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
